Trends in Cardiovascular Medicine
Volume 16, Issue 8 , Pages 292-298 , November 2006

Cardiovascular Polycystins: Insights From Autosomal Dominant Polycystic Kidney Disease and Transgenic Animal Models

References 

  1. Basora N, Nomura H, Berger UV, et al. Tissue and cellular localization of a novel polycystic kidney disease-like gene product, polycystin-L. J Am Soc Nephrol. 2002;13:293–301
  2. Boucher C, Sandford R. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2). Eur J Hum Genet. 2004;12:347–354
  3. Boulter C, Mulroy S, Webb S, et al. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc Natl Acad Sci U S A. 2001;98:12174–12179
  4. Chapman AB, Rubinstein D, Hughes R, et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N Engl J Med. 1992;327:916–920
  5. Chapman AB, Johnson AM, Gabow PA. Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: how to diagnose and who to screen. Am J Kidney Dis. 1993;22:526–531
  6. Conway SJ, Kruzynska-Frejtag A, Kneer PL, et al. What cardiovascular defect does my prenatal mouse mutant have, and why?. Genesis. 2003;35:1–21
  7. Delmas P. Polycystins: polymodal receptor/ion-channel cellular sensors. Pflugers Arch. 2005;451:264–276
  8. Delmas P, Nomura H, Li X, et al. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. J Biol Chem. 2002;277:11276–11283
  9. Delmas P, Nauli SM, Li X, et al. Gating of the polycystin ion channel signaling complex in neurons and kidney cells. FASEB J. 2004;18:740–742
  10. Devuyst O, Persu A, Vo-Cong MT. Autosomal dominant polycystic kidney disease: modifier genes and endothelial dysfunction. Nephrol Dial Transplant. 2003;18:2211–2215
  11. Forman JR, Qamar S, Paci E, et al. The remarkable mechanical strength of polycystin-1 supports a direct role in mechanotransduction. J Mol Biol. 2005;349:861–871
  12. Gabow PA. Autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1993;22:511–512
  13. Gallagher AR, Hidaka S, Gretz N, et al. Molecular basis of autosomal-dominant polycystic kidney disease. Cell Mol Life Sci. 2002;59:682–693
  14. Gao Z, Joseph E, Ruden DM, et al. Drosophila Pkd2 is haploid-insufficient for mediating optimal smooth muscle contractility. J Biol Chem. 2004;279:14225–14231
  15. Gonzalez-Perrett S, Kim K, Ibarra C, et al. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci U S A. 2001;98:1182–1187
  16. Griffin MD, Torres VE, Grande JP, et al. Vascular expression of polycystin. J Am Soc Nephrol. 1997;8:616–626
  17. Guo L, Schreiber TH, Weremowicz S, et al. Identification and characterization of a novel polycystin family member, polycystin-L2, in mouse and human: sequence, expression, alternative splicing, and chromosomal localization. Genomics. 2000;64:241–251
  18. Hanaoka K, Qian F, Boletta A, et al. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature. 2000;408:990–994
  19. Hateboer N, Lazarou LP, Williams AJ, et al. Familial phenotype differences in PKD11. Kidney Int. 1999;56:34–40
  20. Hateboer N, V Dijk MA, Bogdanova N, et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet. 1999;353:103–107
  21. Hughes J, Ward CJ, Peral B, et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet. 1995;10:151–160
  22. Ibraghimov-Beskrovnaya O, Dackowski WR, Foggensteiner L, et al. Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci U S A. 1997;94:6397–6402
  23. Ibraghimov-Beskrovnaya O, Bukanov NO, Donohue LC, et al. Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1. Hum Mol Genet. 2000;9:1641–1649
  24. Kim K, Drummond I, Ibraghimov-Beskrovnaya O, et al. Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A. 2000;97:1731–1736
  25. Kip SN, Hunter LW, Ren Q, et al. [Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype. Circ Res. 2005;96:873–880
  26. Klein IH, Ligtenberg G, Oey PL, et al. Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol. 2001;12:2427–2433
  27. Kocaman O, Oflaz H, Yekeler E, et al. Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2004;43:854–860
  28. Koulen P, Cai Y, Geng L, et al. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol. 2002;4:191–197
  29. Lakkis M, Zhou J. Molecular complexes formed with polycystins. Nephron Exp Nephrol. 2003;93:e3–e8
  30. Lantinga-van Leeuwen IS, Dauwerse JG, Baelde HJ, et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum Mol Genet. 2004;13:3069–3077
  31. Li Q, Dai Y, Guo L, et al. Polycystin-2 associates with tropomyosin-1, an actin microfilament component. J Mol Biol. 2003;325:949–962
  32. Loghman-Adham M, Soto CE, Shen X, et al. Mice with targeted mutations in PK1del134/+, develop salt sensitive hypertension. J Am Soc Nephrol. 2001;12:A2797
  33. Magistroni R, He N, Wang K, et al. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2003;14:1164–1174
  34. Malhas AN, Abuknesha RA, Price RG. Interaction of the leucine-rich repeats of polycystin-1 with extracellular matrix proteins: possible role in cell proliferation. J Am Soc Nephrol. 2002;13:19–26
  35. Maroto R, Raso A, Wood TG, et al. TRPC1 forms the stretch-activated cation channel in vertebrate cells. Nat Cell Biol. 2005;7:179–185
  36. Mochizuki T, Wu G, Hayashi T, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 1996;272:1339–1342
  37. Montell C, Birnbaumer L, Flockerzi V, et al. A unified nomenclature for the superfamily of TRP cation channels. Mol Cell. 2002;9:229–231
  38. Moy GW, Mendoza LM, Schulz JR, et al. The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1. J Cell Biol. 1996;133:809–817
  39. Nauli SM, Zhou J. Polycystins and mechanosensation in renal and nodal cilia. Bioessays. 2004;26:844–856
  40. Nauli SM, Alenghat FJ, Luo Y, et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003;33:129–137
  41. Parnell SC, Magenheimer BS, Maser RL, et al. The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Commun. 1998;251:625–631
  42. Persu A, Stoenoiu MS, Messiaen T, et al. Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet. 2002;11:229–241
  43. Peters DJ, Van de Wal A, Spruit L, et al. Cellular localization and tissue distribution of polycystin-1. J Pathol. 1999;188:439–446
  44. Pirson Y, Chauveau D, Torres V. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2002;13:269–276
  45. Praetorius HA, Spring KR. The renal cell primary cilium functions as a flow sensor. Curr Opin Nephrol Hypertens. 2003;12:517–520
  46. Pritchard L, Sloane-Stanley JA, Sharpe JA, et al. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. Hum Mol Genet. 2000;9:2617–2627
  47. Puri S, Magenheimer BS, Maser RL, et al. Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway. J Biol Chem. 2004;279:55455–55464
  48. Qian F, Germino GG. “Mistakes happen”: somatic mutation and disease. Am J Hum Genet. 1997;61:1000–1005
  49. Qian F, Watnick TJ, Onuchic LF, et al. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell. 1996;87:979–987
  50. Qian F, Germino FJ, Cai Y, et al. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet. 1997;16:179–183
  51. Qian Q, Hunter LW, Li M, et al. Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Hum Mol Genet. 2003;12:1875–1880
  52. Qian Q, Li M, Cai Y, et al. Analysis of the polycystins in aortic vascular smooth muscle cells. J Am Soc Nephrol. 2003;14:2280–2287
  53. Qian F, Wei W, Germino G, et al. The nanomechanics of polycystin-1 extracellular region. J Biol Chem. 2005;280:40723–40730
  54. Rossetti S, Burton S, Strmecki L, et al. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol. 2002;13:1230–1237
  55. Rossetti S, Chauveau D, Kubly V, et al. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet. 2003;361:2196–2201
  56. Schievink WI, Torres VE, Piepgras DG, et al. Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1992;3:88–95
  57. Sutters M, Germino GG. Autosomal dominant polycystic kidney disease: molecular genetics and pathophysiology. J Lab Clin Med. 2003;141:91–101
  58. Torres VE, Cai Y, Chen X, et al. Vascular expression of polycystin-2. J Am Soc Nephrol. 2001;12:1–9
  59. Tsiokas L, Kim E, Arnould T, et al. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci U S A. 1997;94:6965–6970
  60. Tsiokas L, Arnould T, Zhu C, et al. Specific association of the gene product of PKD2 with the TRPC1 channel. Proc Natl Acad Sci U S A. 1999;96:3934–3939
  61. Volk T, Schwoerer AP, Thiessen S, et al. A polycystin-2-like large conductance cation channel in rat left ventricular myocytes. Cardiovasc Res. 2003;58:76–88
  62. Wang D, Strandgaard S. The pathogenesis of hypertension in autosomal dominant polycystic kidney disease. J Hypertens. 1997;15:925–933
  63. Wang D, Iversen J, Strandgaard S. Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2000;11:1371–1376
  64. Wang D, Iversen J, Wilcox CS, et al. Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int. 2003;64:1381–1388
  65. Watnick T, Phakdeekitcharoen B, Johnson A, et al. Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease. Am J Hum Genet. 1999;65:1561–1571
  66. Weston BS, Malhas AN, Price RG. Structure-function relationships of the extracellular domain of the autosomal dominant polycystic kidney disease-associated protein, polycystin-1. FEBS Lett. 2003;538:8–13
  67. Wu G, D'Agati V, Cai Y, et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell. 1998;93:177–188
  68. Wu G, Markowitz GS, Li L, et al. Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat Genet. 2000;24:75–78
  69. Xu GM, Sikaneta T, Sullivan BM, et al. Polycystin-1 interacts with intermediate filaments. J Biol Chem. 2001;276:46544–46552
  70. Yuasa T, Venugopal B, Weremowicz S, et al. The sequence, expression, and chromosomal localization of a novel polycystic kidney disease 1-like gene, PKD1L1, in human. Genomics. 2002;79:376–386
  71. Yuasa T, Takakura A, Denker BM, et al. Polycystin-1L2 is a novel G-protein-binding protein. Genomics. 2004;84:126–138

PII: S1050-1738(06)00114-9

doi: 10.1016/j.tcm.2006.07.002

Trends in Cardiovascular Medicine
Volume 16, Issue 8 , Pages 292-298 , November 2006

Article Tools

* Image Usage & Resolution